CIENCIASMEDICASNEWS: Postmenopausal breast cancer and the benefit of genetic testing

martes, 12 de mayo de 2020

Postmenopausal breast cancer and the benefit of genetic testing

	Breast Cancer
	The latest breast cancer news from News Medical

Postmenopausal breast cancer and the benefit of genetic testing

A new study shows that genetic mutations could be detected in one in 40 women diagnosed with breast cancer before the age of 65 years. The study from Stanford researchers, titled "Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer," was published as a research letter 10th March in the journal JAMA.

			Potential new method of breast cancer treatment using androgen receptor Scientists may have discovered a new therapeutic approach to treat ER+ breast cancer using androgen receptor-stimulating drugs.

			Breast Cancer and Atrial Fibrillation Atrial fibrillation (AFib) is a common heart rhythm problem whereby the heart's two upper chambers, the atria, squeeze out of sync and often rapidly.

	Weight gain could lower woman’s chances of getting breast cancer before menopause Gaining weight from early adulthood is linked to a lower risk of breast cancer before the menopause, a major global study of more than 600,000 women has found.

	New viable therapeutic strategy found for ER+ breast cancer Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments.

	Bacteria-trapping protein may contribute to breast cancer metastasis The protein peptidyl arginine deiminase 4 (PAD4), which enables some immune cells to trap bacteria, promoted breast cancer metastasis in mice when expressed in cancer cells, according to data published in Molecular Cancer Research, a journal of the American Association for Cancer Research.

	Statins may protect against heart damage caused by breast cancer therapies Statins are widely used to lower cholesterol and prevent heart disease and related deaths, but can they also help guard against heart damage caused by certain breast cancer therapies?